<SEC-DOCUMENT>0001062993-24-020516.txt : 20241212
<SEC-HEADER>0001062993-24-020516.hdr.sgml : 20241212
<ACCEPTANCE-DATETIME>20241212092926
ACCESSION NUMBER:		0001062993-24-020516
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20241212
FILED AS OF DATE:		20241212
DATE AS OF CHANGE:		20241212

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Zentek Ltd.
		CENTRAL INDEX KEY:			0001904501
		STANDARD INDUSTRIAL CLASSIFICATION:	MISCELLANEOUS CHEMICAL PRODUCTS [2890]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			A6
		FISCAL YEAR END:			0331

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-41310
		FILM NUMBER:		241543428

	BUSINESS ADDRESS:	
		STREET 1:		24 CORPORATE CT
		CITY:			GUELPH
		STATE:			A6
		ZIP:			N1G 5G5
		BUSINESS PHONE:		(844) 730-9822

	MAIL ADDRESS:	
		STREET 1:		24 CORPORATE CT
		CITY:			GUELPH
		STATE:			A6
		ZIP:			N1G 5G5
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>form6k.htm
<DESCRIPTION>FORM 6-K
<TEXT>
<html>

<head>
    <title>Zentek Ltd.: Form 6-K - Filed by newsfilecorp.com</title>
</head>

<body style="font-size:10pt; font-family:'Times New Roman';">
    <hr width="100%" size="3" color="black" noshade="noshade"><a name="page_1"></a>
    <p style="margin-bottom: 0pt; text-align: center; background-color: #ffffff;"><font style="font-size: 18pt;"><b>UNITED STATES</b></font></p>
    <p style="margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: #ffffff;"><font style="font-size: 18pt;"><b>SECURITIES AND EXCHANGE COMMISSION</b></font></p>
    <p style="margin-top: 0pt; text-align: center; background-color: #ffffff;"><b>Washington, D.C. 20549</b></p>
    <p style="text-align: center; background-color: #ffffff;"><font style="font-size: 18pt;"><b>FORM 6-K</b></font></p>
    <p style="margin-bottom: 0pt; text-align: center; background-color: #ffffff;"><b>REPORT OF FOREIGN PRIVATE ISSUER</b></p>
    <p style="margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: #ffffff;"><b>PURSUANT TO RULE 13a-16 OR 15d-16</b></p>
    <p style="margin-top: 0pt; text-align: center; background-color: #ffffff;"><b>OF THE SECURITIES EXCHANGE ACT OF 1934</b></p>
    <p style="text-align: center; background-color: #ffffff;"><b>For the month of <u>December 2024</u></b></p>
    <p style="text-align: center; background-color: #ffffff;"><b>Commission File Number: <u>001-41310</u></b></p>
    <p style="margin-bottom: 0pt; text-align: center; background-color: #ffffff;"><font style="font-size: 18pt;"><u><b>ZENTEK LTD.</b></u></font></p>
    <p style="margin-top: 0pt; text-align: center; background-color: #ffffff;"><b>(Registrant)</b></p>
    <p style="margin-bottom: 0pt; text-align: center; background-color: #ffffff;"><b>24 Corporate Court</b></p>
    <p style="margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: #ffffff;"><u><b>Guelph, Ontario N1G 5G5 Canada</b></u></p>
    <p style="margin-top: 0pt; text-align: center; background-color: #ffffff;"><b> (Address of Principal Executive Offices)</b></p>
    <p style="background-color: #ffffff; text-align: justify;">Indicate by check mark whether the Registrant files or will file annual reports under cover of Form 20-F or Form 40-F.</p>
    <p style="text-align: center; background-color: #ffffff;">Form 20-F&#160; &#9744;&#160; &#160; &#160; &#160; &#160; &#160; Form 40-F&#160; &#9746;</p>
    <p style="background-color: #ffffff; text-align: justify;">Indicate by check mark if the Registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):&#160; &#9744;</p>
    <p style="background-color: #ffffff; text-align: justify;">Indicate by check mark if the Registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):&#160; &#9744;</p>
    <div style="text-align: center;"><br></div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_2"></a>
    <p style="margin-bottom: 0pt; text-align: center; background-color: #ffffff;"><u><b>SIGNATURES</b></u><br><b> </b></p>
    <p style="text-align: justify;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</p>
    <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" cellspacing="0" cellpadding="0">
        <tr>
            <td style="margin-top: 0pt; margin-bottom: 0pt; width: 50%;">&#160;</td>
            <td style="margin-top: 0pt; margin-bottom: 0pt;" colspan="2"><b>ZENTEK LTD.</b></td>
        </tr>
        <tr>
            <td style="margin-top: 0pt; margin-bottom: 0pt; width: 50%;">&#160;</td>
            <td style="margin-top: 0pt; margin-bottom: 0pt;" colspan="2">(Registrant)</td>
        </tr>
        <tr>
            <td style="margin-top: 0pt; margin-bottom: 0pt; width: 50%;">&#160;</td>
            <td style="margin-top: 0pt; margin-bottom: 0pt; width: 5%;" colspan="1">&#160;</td>
            <td style="margin-top: 0pt; margin-bottom: 0pt; width: 45%;" colspan="1">&#160;</td>
        </tr>
        <tr>
            <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: top; width: 50%;">Date: December 12, 2024</td>
            <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: top; width: 5%;">By</td>
            <td style="vertical-align: top; background-color: #ffffff; border-bottom: 0.75pt solid #000000; width: 45%;">/s/ Wendy Ford</td>
        </tr>
        <tr>
            <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: top; width: 50%;">&#160;</td>
            <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: top; width: 5%;">&#160;</td>
            <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: top; width: 45%;">Wendy Ford</td>
        </tr>
        <tr>
            <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: top; width: 50%;">&#160;</td>
            <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: top; width: 5%;">&#160;</td>
            <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: top; width: 45%;">Chief Financial Officer</td>
        </tr>
    </table>
    <br>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_3"></a>
    <p style="text-align: center;"><u><b>EXHIBIT INDEX</b></u></p>
    <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" cellspacing="0" cellpadding="0">
        <tr>
            <td style="vertical-align: bottom; background-color: #ffffff; width: 10%; white-space: nowrap;"><u><b>Exhibit</b></u></td>
            <td style="margin-top: 0pt; margin-bottom: 0pt; width: 90%; white-space: nowrap;"><u><b>Description of Exhibit</b></u></td>
        </tr>
        <tr>
            <td style="margin-top: 0pt; margin-bottom: 0pt; width: 10%;">&#160;</td>
            <td style="margin-top: 0pt; margin-bottom: 0pt; width: 90%;">&#160;</td>
        </tr>
        <tr>
            <td style="margin-top: 0pt; margin-bottom: 0pt; width: 10%; background-color: #eeeeee;"><a href="exhibit99-1.htm">99.1</a></td>
            <td style="margin-top: 0pt; margin-bottom: 0pt; width: 90%; background-color: #eeeeee;"><a href="exhibit99-1.htm">Press Release dated December 12, 2024 - Zentek Provides Update on International Opportunities</a></td>
        </tr>
    </table>
    <br>
    <hr width="100%" size="5" color="black" noshade="noshade">
</body>

</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>exhibit99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<html>

<head>
    <title>Zentek Ltd.: Exhibit 99.1 - Filed by newsfilecorp.com</title>
</head>

<body style="font-size:10pt; font-family:'Times New Roman';">
    <hr width="100%" size="3" color="black" noshade="noshade"><a name="page_1"></a>
    <p style="text-align: center;"><img src="exhibit99-1x001.jpg" style="width: 219px;" height="51"></p>
    <p style="text-align: center;"><font style="font-size: 14pt;"><b>Zentek Provides Update on International Opportunities</b></font></p>
    <p style="text-align: justify; background-color: #ffffff;"><b>Guelph, ON - December 12, 2024, Zentek Ltd.</b> ("<b>Zentek</b>"<b> </b>or the "<b>Company</b>") (Nasdaq: ZTEK; TSX-V: ZEN), an intellectual property development and commercialization company, has signed a Memorandum of Understanding ("MOU") with Al-Ramez International Group - through Saudi Excellence Holding Company - establishing a strategic partnership to drive innovation and commercialization in advanced technologies across the Kingdom of Saudi Arabia ("KSA") and the Middle East and North Africa ("MENA") region on November 14<sup>th</sup> 2024.</p>
    <p>&#160;</p>
    <p style="text-align: justify; background-color: #ffffff;"><b>Memorandum of Understanding Overview</b></p>
    <p style="text-align: justify; background-color: #ffffff;">The MOU outlines a collaborative framework where Zentek intends to contribute intellectual property, product licensing, and research and development expertise, while<b> </b>Al-Ramez International Group intends to provide marketing support, investor relations, financing, and access to the KSA and MENA market. Together, the parties aim to achieve several key objectives:</p>
    <div style="margin-top: 14pt; margin-left: 18pt; margin-bottom: 14pt; background-color: #ffffff;">
        <p style="margin-left: 18pt; text-indent: -18pt; text-align: justify;">1.<font style="width: 10.49pt; text-indent: 0pt; display: inline-block;">&#160;</font>Graphene Production Hub: Develop a world-class graphene production facility in the KSA focusing on ZenGUARD&#8482; technologies for distribution in the KSA and across the MENA region.</p>
    </div>
    <div style="margin-left: 18pt; background-color: #ffffff;">
        <p style="margin-left: 18pt; text-indent: -18pt; text-align: justify;">2.<font style="width: 10.49pt; text-indent: 0pt; display: inline-block;">&#160;</font>Commercialization Hub: Establish a centralized hub for the commercialization of Zentek's current and future graphene technologies.</p>
    </div>
    <div style="margin-left: 18pt; background-color: #ffffff;">
        <p style="margin-left: 18pt; text-indent: -18pt; text-align: justify;">3.<font style="width: 10.49pt; text-indent: 0pt; display: inline-block;">&#160;</font>Biotechnology Expansion: Support local research and production initiatives by advancing and commercializing Triera Biosciences Ltd.'s ("Triera") multivalent aptamer technology for rapid drug discovery within the KSA and MENA region.</p>
    </div>
    <div style="margin-left: 18pt; background-color: #ffffff;">
        <p style="margin-left: 18pt; text-indent: -18pt; text-align: justify;">4.<font style="width: 10.49pt; text-indent: 0pt; display: inline-block;">&#160;</font>Strategic Investment in Resources: Facilitate investment and development of the Albany Graphite Deposit to support the North American supply chain for advanced materials, including anode material for the electric vehicle market.</p>
    </div>
    <div style="margin-left: 18pt; background-color: #ffffff;">
        <p style="margin-left: 18pt; text-indent: -18pt; text-align: justify;">5.<font style="width: 10.49pt; text-indent: 0pt; display: inline-block;">&#160;</font>Aptamer Research and Development: Secure funding for Triera to establish and expand aptamer research and development in conjunction with a Saudi university and private sector partners and build a production facility for the KSA and MENA region.</p>
    </div>
    <p style="text-align: justify; background-color: #ffffff;">This MOU, a direct result of the groundwork laid during trips to the United Arab Emirates and Saudi Arabia, reflects the shared vision of fostering advanced, efficient, and affordable solutions to meet the needs of industries and institutions across the region. The potential partnership also considers exclusivity and joint ventures related to the Company's opportunities that may also position Al-Ramez International Group as a key equity partner. The Company believes this potential partnership could be a significant step toward successfully commercializing many of its opportunities and creating&#160; benefits for both parties.</p>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_2"></a>
    <p style="text-align: justify; background-color: #ffffff;">"We are very excited to be collaborating with Sheik Abdullah Zaid Al-Meleihi and the Al-Ramez International Group to bring the Zentek platform to the KSA and MENA region. The vast reach, track record, relationships and vision for the future of this group will provide a tremendous&#160; partnership opportunity for Zentek in the region. Our Company has the potential to play a significant role in the Saudi Green Initiative Vision 2030 as the Kingdom looks to reduce its carbon footprint through significant investments in new technologies," said Greg Fenton, Zentek CEO.</p>
    <p style="text-align: justify; background-color: #ffffff;"><b>International Expansion and Export Strategy</b></p>
    <p style="text-align: justify; background-color: #ffffff;">To support these and other international business opportunities, the Company has applied for and been accepted into the World Trade Centre Toronto's Trade Accelerator Program (TAP) | Life Sciences Commercialization for Global Success.</p>
    <p style="text-align: justify; background-color: #ffffff;">The TAP program focuses on the following areas:</p>
    <div style="margin-left: 18pt; background-color: #ffffff;">
        <p style="margin-left: 18pt; text-indent: -18pt; text-align: justify;">&#8226;<font style="width: 13.4pt; text-indent: 0pt; display: inline-block;">&#160;</font>Understanding key concepts in medical technology commercialization for international markets</p>
    </div>
    <div style="margin-left: 18pt; background-color: #ffffff;">
        <p style="margin-left: 18pt; text-indent: -18pt; text-align: justify;">&#8226;<font style="width: 13.4pt; text-indent: 0pt; display: inline-block;">&#160;</font>Ensuring products meet healthcare needs while demonstrating clear value</p>
    </div>
    <div style="margin-left: 18pt; background-color: #ffffff;">
        <p style="margin-left: 18pt; text-indent: -18pt; text-align: justify;">&#8226;<font style="width: 13.4pt; text-indent: 0pt; display: inline-block;">&#160;</font>Validating target markets and creating a comprehensive export plan to guide global commercialization efforts</p>
    </div>
    <div style="margin-left: 18pt; background-color: #ffffff;">
        <p style="margin-left: 18pt; text-indent: -18pt; text-align: justify;">&#8226;<font style="width: 13.4pt; text-indent: 0pt; display: inline-block;">&#160;</font>Establishing profitable entities that serve both local and global customer bases</p>
    </div>
    <p style="text-align: justify; background-color: #ffffff;"><b>About Zentek Ltd. </b></p>
    <p style="text-align: justify;">Zentek is an ISO 13485:2016 certified intellectual property technology company focused on the research, development and commercialization of novel products seeking to give the Company's commercial partners a competitive advantage by making their products better, safer, and greener.</p>
    <p style="text-align: justify;">Zentek's patented technology platform ZenGUARD&#8482; is shown to have enhanced viral filtration efficiency for surgical masks and HVAC (heating, ventilation, and air conditioning) systems. Zentek's ZenGUARD&#8482; production facility is located in Guelph, Ontario.</p>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_3"></a>
    <p style="text-align: justify;"><b>For further information on Zentek: </b></p>
    <p style="text-align: justify; background-color: #ffffff;"><font style="color: #0563c1;"><u>investorrelations@zentek.com</u></font></p>
    <p style="margin-bottom: 0pt; text-align: justify; background-color: #ffffff;">Ryan Shacklock</p>
    <p style="margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: #ffffff;">Senior VP, Strategy &amp; Business Development</p>
    <p style="margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: #ffffff;">Email: <font style="color: #0563c1;"><u>rshacklock@zentek.com</u></font></p>
    <p style="margin-top: 0pt; text-align: justify; background-color: #ffffff;">Phone: 306-270-9610</p>
    <p style="text-align: justify; background-color: #ffffff;">To find out more about Zentek, please visit our website at <font style="color: #0000ff;"><u>www.Zentek.com</u></font>. A copy of this news release and all material documents in respect of the Company may be obtained on Zentek's SEDAR+ profile at <font style="color: #0000ff;"><u>http://www.sedarplus.ca/</u></font>.</p>
    <p style="text-align: justify; background-color: #ffffff;"><b><br>Forward-Looking Statements </b></p>
    <p style="text-align: justify; background-color: #ffffff;">This news release contains forward-looking statements. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. Although Zentek believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information, which only applies as of the date of this news release, and no assurance can be given that such events will occur in the disclosed time frames or at all. Zentek disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, other than as required by law.</p>
    <p style="text-align: justify; background-color: #ffffff;">Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.</p>
    <hr width="100%" size="5" color="black" noshade="noshade">
</body>

</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>exhibit99-1x001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 exhibit99-1x001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  0" P,# @0# P,$! 0$!0D&!04%
M!0L(" 8)#0L-#0T+# P.$!01#@\3#PP,$A@2$Q46%Q<7#A$9&QD6&A06%Q;_
MVP!# 00$! 4%!0H&!@H6#PP/%A86%A86%A86%A86%A86%A86%A86%A86%A86
M%A86%A86%A86%A86%A86%A86%A86%A;_P  1"  S -L# 2(  A$! Q$!_\0
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M5Z]XVUC78_B5HT*:GJ$]VL3:=*2@DD9PI.[G&[%97_#M7Q=_T5#1?_!;+_\
M%5^C5?,?_!13]IVU^#/A%O"OA:YCF\;ZQ ?(VX8:7$>//<=-W]Q3U/)X'/CF
M9^;/[2GPRD^$'Q=U#P'/XBT_7)].2,S75B"JJSH&,;*?NL,C(R>H^E>P?\$J
M_AMXJ\4_M.Z/XSTZQ9=#\)R//J%]*"(]SQ.B1(?XG._..P!)QQGS+]FSX2>,
M?C_\7QHFFR2MYTOVK6M6G!9;6-FRTCGN['.T?Q'\2/V$^"OP[\+_  L^'=AX
M,\(V*VNGV*<MC]Y<2'[TLC?Q.QZG\.@H \7_ ."D/[1,_P $OAS;Z1X:=?\
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'G-6E)L__V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
